Regulatory Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Therapeutic
Pharmacy Only
Formulation Information
TABLET
**DOSAGE:** **Adults:** 1–2 tablets These doses may be given 3–4 times daily as required (Max. 6 tablets a day). **Children and adolescents** Codeine should not be used in children below 12 years old. In those 12 years old and above, codeine may be used for the short-term treatment of acute moderate pain which is not relieved by analgesics such as Ibuprofen or paracetamol alone. The lowest effective dose should be used for the shortest possible duration.
ORAL
Medical Information
**INDICATIONS:** For relief of aches and pain e.g., headache, toothache and dysmenorrhoea. Codeine is not recommended for the treatment of post-operative pain following surgical procedures such as tonsillectomy or adenoidectomy in children and adolescents below 18 years old due to the increased risk of respiratory depression.
**CONTRA-INDICATIONS:** Contraindicated in patients with bronchial asthma, increased intracranial pressure, respiratory depression and nephropathy.
N02BE51
paracetamol, combinations excl. psycholeptics
Manufacturer Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
BEACONS PHARMACEUTICALS PTE. LTD.
SRI KRISHNA PHARMACEUTICALS LTD [Intermediate manufacturer]
Active Ingredients
Documents
Package Inserts
Pacofen Tablet PIL.pdf
Approved: March 10, 2022